Bellevue Life Sciences Acquisition Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 100,000 | 2.47% |
General Public | 253,762 | 6.28% |
Hedge Funds | 531,578 | 13.2% |
Institutions | 1,120,881 | 27.7% |
Private Companies | 2,035,000 | 50.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,355,000 | US$14.8m | -33.4% | no data | |||
680,000 | US$7.4m | 0% | no data | |||
268,878 | US$2.9m | -7.76% | 0.28% | |||
262,700 | US$2.9m | 0% | 0.02% | |||
245,115 | US$2.7m | 0% | 0.12% | |||
200,000 | US$2.2m | 0% | 2.44% | |||
193,376 | US$2.1m | -47.7% | 0.05% | |||
124,995 | US$1.4m | -50% | no data | |||
99,358 | US$1.1m | -69.2% | 0.06% | |||
86,650 | US$943.6k | 0% | 0.03% | |||
65,000 | US$707.8k | 0% | 0.32% | |||
39,781 | US$433.2k | 47.1% | 2.13% | |||
21,990 | US$239.5k | 59.1% | no data | |||
20,000 | US$217.8k | 0% | no data | |||
20,000 | US$217.8k | 0% | no data | |||
20,000 | US$217.8k | 0% | no data | |||
20,000 | US$217.8k | 0% | no data | |||
20,000 | US$217.8k | 0% | no data | |||
16,328 | US$177.8k | 0% | 0.13% | |||
15,140 | US$164.9k | 0% | no data | |||
8,592 | US$93.6k | 6,940% | no data | |||
4,365 | US$47.5k | 1.09% | no data | |||
105 | US$1.1k | 6.06% | no data | |||
86 | US$937.4 | -5.49% | no data |